Literature DB >> 26722496

Association between tumor necrosis factor-α gene polymorphisms and diffuse large B-cell lymphoma in Chinese Han population: evidence from two center case-control study and a meta-analysis.

Cui Yang1, Wanling Wang1, Youmei Zi1, Xiaolin Han1, Xiaoxue Qin1, Jingdong Li1, Honggang Ren2.   

Abstract

OBJECTIVES: The tumor necrosis factor-α (TNF-α) gene, which plays crucial roles in tumorigenesis, is reported to be an independent marker for cancer. This study aims to examine the association between the TNF-α G308A polymorphism and DLBCL risk based on the two center case-control studies and meta-analysis.
METHODS: In the current study, we performed a two centers case-control study to investigate the effect of the TNF-α G308A polymorphism on DLBCL risk in Chinese Han population. A meta-analysis including 10 published datasets along with current dataset, including 111 comparisons containing 34,041 cases and 42,730 controls were enrolled, was next performed to further confirm the association after literature search was conducted and relevant studies were identified from PubMed, Embase, and Web of Science.
RESULTS: The TNF-α -308A allele was associated with a significantly increased DLBCL risk in the two independent patient case-control studies and additionally for pooled analysis from the two sets (P<0.05 for both). The result of meta-analysis further demonstrated that the A allele of -308A was significantly correlated with DLBCL risk under the allelic model (OR=1.35, 95% CI=1.27-1.44) without heterogeneity by fixed-effects model analysis (Q=17.30, P=0.139). Moreover, sensitivity analysis supported the robustness of this meta-analysis.
CONCLUSION: This study suggested that -308A polymorphism may be associated with the susceptibility of DLBCL in a Chinese population. The further meta-analysis provides additional evidence supporting the above result that the risk allele of the -308A polymorphism may increase DLBCL risk.

Entities:  

Keywords:  TNF-α; diffuse large B-cell lymphoma; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26722496      PMCID: PMC4680441     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas.

Authors:  René Scholtysik; Inga Nagel; Markus Kreuz; Inga Vater; Maciej Giefing; Carsten Schwaenen; Swen Wessendorf; Lorenz Trümper; Markus Loeffler; Reiner Siebert; Ralf Küppers
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

3.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

4.  A method for meta-analysis of molecular association studies.

Authors:  Ammarin Thakkinstian; Patrick McElduff; Catherine D'Este; David Duffy; John Attia
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

5.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.

Authors:  E Louis; D Franchimont; A Piron; Y Gevaert; N Schaaf-Lafontaine; S Roland; P Mahieu; M Malaise; D De Groote; R Louis; J Belaiche
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.

Authors:  Pia Fernberg; Ellen T Chang; Kristina Duvefelt; Henrik Hjalgrim; Sandra Eloranta; Karina Meden Sørensen; Anna Porwit; Keith Humphreys; Mads Melbye; Karin Ekström Smedby
Journal:  Cancer Causes Control       Date:  2010-01-20       Impact factor: 2.506

8.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.

Authors:  Lindsay M Morton; Sophia S Wang; Wendy Cozen; Martha S Linet; Nilanjan Chatterjee; Scott Davis; Richard K Severson; Joanne S Colt; Mohammad A Vasef; Nathaniel Rothman; Aaron Blair; Leslie Bernstein; Amanda J Cross; Anneclaire J De Roos; Eric A Engels; David W Hein; Deirdre A Hill; Linda E Kelemen; Unhee Lim; Charles F Lynch; Maryjean Schenk; Sholom Wacholder; Mary H Ward; Shelia Hoar Zahm; Stephen J Chanock; James R Cerhan; Patricia Hartge
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.

Authors:  Chuen-Ming Shih; Yao-Ling Lee; Hui-Ling Chiou; Wei Chen; Gee-Chen Chang; Ming-Chih Chou; Long-Yau Lin
Journal:  Lung Cancer       Date:  2006-02-14       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.